project id: TCGA-UCEC; case submitter id: TCGA-BS-A0TJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 59; days to birth: -21663; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1947; age at diagnosis: 21663; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2068.0; figo stage: Stage IC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1431; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-BS-A0TJ-01A-11; percent lymphocyte infiltration: 1.0; percent normal cells: 0.0;